HOME >> BIOLOGY >> NEWS
EPA selects Phylonix to screen compound library in zebrafish

Cambridge, MA April 12, 2007 -- Phylonix Pharmaceuticals, Inc. today announced it has been awarded a major, two-year contract for up to $4.3 million by the Environmental Protection Agency (EPA) as part of the agencys ToxCast project to correlate compounds having known toxicities with biological activities in a zebrafish test system.

"We are very pleased that the EPA has chosen Phylonix to participate in the ToxCast project because it validates our significant capabilities and the superior quality of our eZ-ScreensTM zebrafish-based assays," stated Patricia McGrath, Phylonix President and Chief Executive Officer. "The ToxCast award is further confirmation that this model organism can be used to predict compound effects in humans. In addition, the contract will complement our work performed for the pharmaceutical industry to assess toxicity and efficacy for preclinical studies."

The EPA is exploring the use of zebrafish as a screening tool to complement the biochemical, cellular, genomic and metabolomic assays that will be the basis of the ToxCast project being developed by the agency for use in prioritization of potential environmental toxicants for further study. The National Center for Computational Toxicology (NCCT) of the Office and Research and Development of EPA has made multi-year awards to eight companies, including Phylonix, for the generation of High Throughput Screening (HTS) data in support of the ToxCast program. It is estimated there are more than 10,000 environmental chemicals from EPA programs that need prioritizing for further testing.

There is considerable interest in using zebrafish as a model organism of vertebrate biology because of the accessibility of their central nervous system, digestive system, and cardiovascular system to functional study during compound exposure in relatively high-throughput format. All essential components of vertebrate form and organ development are mimicked in the transparent zebrafish and
'"/>

Contact: Edward O'Lear
ed.olear@phylonix.com
617-441-6700
Phylonix
12-Apr-2007


Page: 1 2

Related biology news :

1. Energy department selects 3 Bioenergy Research Centers for $375 million in federal funding
2. OneWorld Health selects Odyssey Research for phase 4 study in India
3. NIH selects Childrens Hospital as Center of Excellence to train future generations of scientists
4. NIH selects Purdue to use phi29 DNA packaging motor for National Nanomedicine Development Center
5. IUBMB selects Wiley to publish Biochemistry and Molecular Biology Education
6. NIH selects Pittsburgh institute as leader for HIV/AIDS prevention efforts
7. EMBO selects Europes best young independent scientists
8. NIH selects Burnham Institute for Exploratory Center for Human Embryonic Stem Cell Research
9. NHGRI selects 13 new targets for large-scale sequencing program
10. Phylonix awarded National Science Foundation Phase II SBIR for zebrafish screening
11. ACMG recognizes progress made in newborn screening

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/18/2020)... TORONTO (PRWEB) , ... July 17, 2020 , ... Commercial ... hangs on pharma’s ability to discover a COVID cure or vaccine, the global economic ... competitive and price pressure is not going away and capturing full value from every ...
(Date:7/2/2020)... (PRWEB) , ... July 02, ... ... Biology Systems, B.V. (MBS) has announced a publication detailing the use of ... reverse transcription polymerase chain reaction (RT-PCR) in 16 minutes. The article, titled ...
(Date:6/25/2020)... ... June 24, 2020 , ... ... software-driven clinical data services that accelerate drug development, is collaborating with Karyopharm Therapeutics ... inhibitor, in hospitalized patients with severe COVID-19. This is the first study of ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... Texas (PRWEB) , ... July 29, 2020 , ... ... solutions today announced the launch of its new tagline, “BUILDING FOR LIFE.” The ... biopharmaceutical industry and around the globe, requiring fast track capacity to provide patients ...
(Date:7/31/2020)... ... July 29, 2020 , ... The SDX® Respiratory Gating ... countries, has reached its 20th anniversary of worldwide use. Introduced in the US ... universities including University of Pennsylvania, University of Michigan, University of Maryland, University of ...
(Date:7/18/2020)... , ... July 16, 2020 , ... ... to aid in the early detection and prevention of high-burden diseases, and Centric ... US-based hospitals and healthcare organizations to utilize existing data in order to identify ...
(Date:7/10/2020)... LEXINGTON, Mass. (PRWEB) , ... July 09, 2020 ... ... novel approaches to cell therapy, today announced the hiring of Allen R. Nissenson, ... executive team and oversee the clinical development of Sentien’s lead product, SBI-101. ...
Breaking Biology Technology:
Cached News: